GoodRx reports that GLP-1 medications will expand in use and accessibility, with new oral options and evolving insurance ...
A scientist has explained why 'healthy people' who are taking GLP-1 drugs are actually 'part of the experiment' as the drug ...
The study emphasizes the importance of vigilance with diet and exercise, among other things, to reduce CV risk in type 2 ...
USDA data shows snack sales holding steady in 2024, even as GLP-1 weight loss drug use rises, highlighting shifting consumer ...
Glucagon-like peptide-1 receptor agonists (GLP-1s) are a class of medication that includes Ozempic®, Wegovy®, and Saxenda®. Some GLP-1s are diabetes drugs, but you can also take a GLP-1 for weight ...
Fact checked by Nick Blackmer New research suggests prolonged GLP-1 use may be linked to a higher risk of osteoporosis and ...
Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of Type 2 diabetes drugs that improves blood sugar and may also lead to weight loss. These drugs — including ...
In a new trial, people who switched to the experimental daily GLP-1 pill orforglipron were able to keep off most of the weight they had lost taking Wegovy or Zepbound. People who switched from Wegovy ...
Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...
If you're taking a GLP-1 medication for weight loss, you may have questions about managing side effects and whether to take nutritional supplements to support your health. As a pharmacist, I' ...
GI side effects from GLP-1s may cause patients to drop the medications or turn to OTC remedies. Gastroenterologists don’t ...
Whether it's about promoting protein or smaller portions, the restaurant industry is preparing for a shift in consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results